We are live on ! Find out more
GCM

Gruss Capital Management Portfolio holdings

AUM $715M
1-Year Est. Return 9.91%
This Fund
S&P 500
This Quarter Est. Return
+13.08%
1 Year Est. Return
+9.91%
3 Year Est. Return
+62.11%
5 Year Est. Return
+60.72%
10 Year Est. Return
AUM
$3.09B
AUM Growth
-$77.2M
Cap. Flow
-$182M
Cap. Flow %
-5.9%
Top 10 Hldgs %
60.39%
Holding
105
New
26
Increased
13
Reduced
18
Closed
24

Top Buys

Rank Stock Value
1
TCO
Taubman Centers Inc.
TCO
+$35.2M
2
KEY icon
KeyCorp
KEY
+$31.2M
3
SLGN icon
Silgan Holdings
SLGN
+$21.8M
4
YPF icon
YPF
YPF
+$16.5M
5
MSGS icon
Madison Square Garden
MSGS
+$14.9M

Sector Composition

Rank Sector Weight
1 Communication Services 6.58%
2 Energy 3.15%
3 Consumer Discretionary 2.57%
4 Financials 2.33%
5 Technology 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELECU
51
DELISTED
Electrum Special Acquisition Corporation
ELECU
$3.98M 0.13%
400,000
BLVDU
52
DELISTED
Boulevard Acquisition Corp. II
BLVDU
$3.96M 0.13%
400,000
QPACU
53
DELISTED
Quinpario Acquisition Corp. 2 Unit
QPACU
$3.92M 0.13%
400,000
CCXI
54
DELISTED
ChemoCentryx, Inc.
CCXI
$3.9M 0.13%
482,000
NG icon
55
NovaGold Resources
NG
$2.56B
$3.79M 0.12%
+900,000
New +$3.46M
TRQ
56
DELISTED
Turquoise Hill Resources Ltd
TRQ
$3.4M 0.11%
134,000
+9,000
+7% +$244K
ANTH
57
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$3.28M 0.11%
88,250
CIE
58
DELISTED
Cobalt International Energy, Inc
CIE
$3.24M 0.1%
+40,000
New +$4.4M
TTPH
59
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$3.01M 0.1%
15,000
EAGLU
60
DELISTED
Double Eagle Acquisition Corp.
EAGLU
$3M 0.1%
300,000
ADVM
61
DELISTED
Adverum Biotechnologies
ADVM
$2.48M 0.08%
26,000
CASC
62
DELISTED
Cascadian Therapeutics, Inc.
CASC
$2.46M 0.08%
184,333
CCO icon
63
Clear Channel Outdoor Holdings
CCO
$1.23B
$2.32M 0.08%
+414,406
New +$2.56M
IRS
64
IRSA Inversiones y Representaciones
IRS
$1.29B
$2.25M 0.07%
189,940
-744,467
-80% -$10.8M
PACEU
65
DELISTED
Pace Holdings Corp.
PACEU
$2.04M 0.07%
200,000
QLTI
66
DELISTED
QLT Inc
QLTI
$2.04M 0.07%
765,000
AVEO
67
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.97M 0.06%
156,383
IAG icon
68
IAMGOLD
IAG
$8.2B
$1.56M 0.05%
+1,100,000
New +$1.8M
FRP
69
DELISTED
Fairpoint Communications, Inc.
FRP
$1.45M 0.05%
90,000
-40,000
-31% -$664K
CMRX
70
DELISTED
Chimerix, Inc.
CMRX
$1.43M 0.05%
+160,000
New +$5.76M
KIN
71
DELISTED
Kindred Biosciences, Inc.
KIN
$1.12M 0.04%
330,000
CVO
72
DELISTED
Cenevo, Inc.
CVO
$959K 0.03%
137,500
SPHS
73
DELISTED
Sophiris Bio, Inc.
SPHS
$958K 0.03%
538,000
GCVRZ
74
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$619K 0.02%
5,500,000
RPRX
75
DELISTED
Repros Therapeutics Inc.
RPRX
$368K 0.01%
304,000

Similar funds

Gruss Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Gruss Capital Management held 105 positions worth $3.09B, down 2.4% from $3.17B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Gruss Capital Management withdrew a net $182M in Q4 2015, closing 24 positions and reducing 18 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 6.6% of assets, down from 13% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Gruss Capital Management opened a new position in KeyCorp worth $31.4M.

  • Gruss Capital Management's largest Q4 2015 buy was KeyCorp: 2,380,000 shares worth $31.4M.
  • Gruss Capital Management added most to Taubman Centers Inc. in Q4 2015, an estimated $35.2M increase.
  • Gruss Capital Management's biggest Q4 2015 reduction was Yahoo Inc, cutting an estimated $28.4M.
  • Gruss Capital Management fully exited TIME WARNER CABLE INC NEW COM STK in Q4 2015, selling an estimated $167M.
  • Gruss Capital Management's ten largest holdings make up 60% of its $3.09B portfolio in Q4 2015.
  • Gruss Capital Management opened 26 new positions and closed 24 in Q4 2015.
  • Gruss Capital Management's portfolio value fell 2.4% quarter-over-quarter to $3.09B.

Based on Gruss Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.